The fully linked HTML version of this article has now been published.
Development ePress online publication date 15 Jun 2005
doi: 10.1242/dev.01888
Research article: Development and disease
Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period
Gavin Thurston*,
Quan Wang,
Fabienne Baffert,
John Rudge,
Nicholas Papadopoulos,
Danielle Jean-Guillaume,
Stanley Wiegand,
George D. Yancopoulos,
and
Donald M. McDonald
* Author for correspondence (e-mail: gavin.thurston{at}regeneron.com)
Early in development, endothelial cells proliferate, coalesce, and sprout to form a primitive plexus of undifferentiated microvessels. Subsequently, this plexus remodels into a hierarchical network of different-sized vessels. Although the processes of proliferation and sprouting are well studied and are dependent on the angiogenic growth factor VEGF, the factors involved in subsequent vessel remodeling are poorly understood. Here, we show that angiopoietin 1 can induce circumferential vessel enlargement, specifically on the venous side of the circulation. This action is due to the ability of angiopoietin 1 to promote endothelial cell proliferation in the absence of angiogenic sprouting; vessel growth without sprouting has not been ascribed to other vascular growth factors, nor has specificity for a particular segment of the vasculature. Moreover, angiopoietin 1 potently mediates widespread vessel enlargement only during a brief postnatal period, in particular, prior to the fourth postnatal week, corresponding to stages in which VEGF inhibition causes widespread vessel regression. These findings show that angiopoietin 1 has a potentially unique role among the vascular growth factors by acting to enlarge blood vessels without inducing sprouting, and also define a critical window of vascular plasticity in neonatal development. Finding the key molecular factors that regulate this plasticity may prove crucial to the further development of pro- and anti-angiogenic therapies.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. S. Herbst, D. Hong, L. Chap, R. Kurzrock, E. Jackson, J. M. Silverman, E. Rasmussen, Y.-N. Sun, D. Zhong, Y. C. Hwang, et al.
Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors
J. Clin. Oncol.,
July 20, 2009;
27(21):
3557 - 3565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H.J. Salmon, C. R. Neal, L. M. Sage, C. A. Glass, S. J. Harper, and D. O. Bates
Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx
Cardiovasc Res,
July 1, 2009;
83(1):
24 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Holopainen, H. Huang, C. Chen, K. E. Kim, L. Zhang, F. Zhou, W. Han, C. Li, J. Yu, J. Wu, et al.
Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment
Cancer Res.,
June 1, 2009;
69(11):
4656 - 4664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Winderlich, L. Keller, G. Cagna, A. Broermann, O. Kamenyeva, F. Kiefer, U. Deutsch, A. F. Nottebaum, and D. Vestweber
VE-PTP controls blood vessel development by balancing Tie-2 activity
J. Cell Biol.,
May 18, 2009;
185(4):
657 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Cuddihy, S. Ge, J. Zhu, J. Jang, A. Chidgey, G. Thurston, R. Boyd, and G. M. Crooks
VEGF-mediated cross-talk within the neonatal murine thymus
Blood,
March 19, 2009;
113(12):
2723 - 2731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Chung, G. Han, M. Seshadri, B. M. Gillard, W.-d. Yu, B. A. Foster, D. L. Trump, and C. S. Johnson
Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo
Cancer Res.,
February 1, 2009;
69(3):
967 - 975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Benest, O. A. Stone, W. H. Miller, C. P. Glover, J. B. Uney, A. H. Baker, S. J. Harper, and D. O. Bates
Arteriolar Genesis and Angiogenesis Induced by Endothelial Nitric Oxide Synthase Overexpression Results in a Mature Vasculature
Arterioscler Thromb Vasc Biol,
August 1, 2008;
28(8):
1462 - 1468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mofarrahi, T. Nouh, S. Qureshi, L. Guillot, D. Mayaki, and S. N. A. Hussain
Regulation of angiopoietin expression by bacterial lipopolysaccharide
Am J Physiol Lung Cell Mol Physiol,
May 1, 2008;
294(5):
L955 - L963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Papanicolaou, Y. Izumiya, and K. Walsh
Forkhead Transcription Factors and Cardiovascular Biology
Circ. Res.,
January 4, 2008;
102(1):
16 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Naciff, G. J. Overmann, S. M. Torontali, G. J. Carr, Z. S. Khambatta, J. P. Tiesman, B. D. Richardson, and G. P. Daston
Uterine Temporal Response to Acute Exposure to 17{alpha}-Ethinyl Estradiol in the Immature Rat
Toxicol. Sci.,
June 1, 2007;
97(2):
467 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Eun Kim, C.-H. Cho, H.-Z. Kim, P. Baluk, D. M. McDonald, and G. Young Koh
In Vivo Actions of Angiopoietins on Quiescent and Remodeling Blood and Lymphatic Vessels in Mouse Airways and Skin
Arterioscler Thromb Vasc Biol,
March 1, 2007;
27(3):
564 - 570.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsui, M. Kanai-Azuma, K. Hara, S. Matoba, R. Hiramatsu, H. Kawakami, M. Kurohmaru, P. Koopman, and Y. Kanai
Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice
J. Cell Sci.,
September 1, 2006;
119(17):
3513 - 3526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P.J. Brindle, P. Saharinen, and K. Alitalo
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Circ. Res.,
April 28, 2006;
98(8):
1014 - 1023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Baffert, T. Le, B. Sennino, G. Thurston, C. J. Kuo, D. Hu-Lowe, and D. M. McDonald
Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling
Am J Physiol Heart Circ Physiol,
February 1, 2006;
290(2):
H547 - H559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Baffert, T. Le, G. Thurston, and D. M. McDonald
Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules
Am J Physiol Heart Circ Physiol,
January 1, 2006;
290(1):
H107 - H118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Cascone, L. Napione, F. Maniero, G. Serini, and F. Bussolino
Stable interaction between {alpha}5{beta}1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1
J. Cell Biol.,
September 12, 2005;
170(6):
993 - 1004.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2005